DMD Simcyp

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on January 13, 2006; DOI: 10.1124/dmd.105.006825


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.105.006825v1
34/4/660    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reed, J. R
Right arrow Articles by Backes, W. L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reed, J. R
Right arrow Articles by Backes, W. L


Received for publication August 4, 2005.
Revised January 4, 2006.
Accepted for publication January 11, 2006.

An Evaluation of Methods for the Reconstitution of Cytochromes P450 and NADPH P450 Reductase into Lipid Vesicles

James R Reed 1*, Rusty W Kelley 1, Wayne L Backes 2

1 LSU Health Science Center 2 LSU Health Sciences Center

* Address correspondence to: E-mail: rreed{at}lsuhsc.edu

Abstract

Two methods (cholate dialysis and cholate gel filtration) used to incorporate cytochromes P450 and reductase into unilamellar phospholipid vesicles were compared to a standard reconstituted system (SRS) where the proteins were reconstituted with preformed liposomes. Both cholate dialysis and gel filtration methods were comparable in their ability to physically incorporate reductase and either CYP2B4 or CYP1A2 into phospholipid, as determined by the elution of enzymes in the void volume using size exclusion chromatography (MW cutoff - 5,000,000 Da). Incorporation of these proteins was more efficient with both cholate methods than when reductase and P450 were mixed with preformed vesicles (SRS). Using either cholate method, greater than 85% of the P450 was physically incorporated into the phospholipids vesicles, whereas less than 40% of the P450 was physically incorporated into the phospholipids vesicles using the SRS. Catalytic activities of the vesicular preparations of reductase and either CYP1A2 or CYP2B4 also were significantly higher than those resulting from the SRS using dilaurylphosphatidylcholine. Although both cholate dialysis and gel filtration methods improved protein incorporation when compared to preincubation of proteins with preformed liposomes, reductase incorporation was dependent on the relative amount of reductase used. Reductase incorporation was complete at a 0.2:1 reductase to P450 ratio; however, the efficiency of incorporation decreased to <50% at equimolar reductase to P450. Interestingly, reductase incorporation was higher in the presence of CYP1A2 than with CYP2B4. Both cholate methods resulted in the loss of a proportion of spectrally detectable carbon monoxyferrous P450, resulting from incubation of the proteins with detergent.


Key words: CYP1A, CYP2B, cytochrome P450, cytochrome P450 function


This article has been cited by other articles:


Home page
Drug Metab. Dispos.Home page
J. R. Reed, L. M. Brignac-Huber, and W. L. Backes
Physical Incorporation of NADPH-Cytochrome P450 Reductase and Cytochrome P450 into Phospholipid Vesicles Using Glycocholate and Bio-Beads
Drug Metab. Dispos., March 1, 2008; 36(3): 582 - 588.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. V. Pandey, P. Kempna, G. Hofer, P. E. Mullis, and C. E. Fluck
Modulation of Human CYP19A1 Activity by Mutant NADPH P450 Oxidoreductase
Mol. Endocrinol., October 1, 2007; 21(10): 2579 - 2595.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.